Boulder Hill Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Boulder Hill Capital Management's RGEN Position: Q1 2022 in Review
Boulder Hill Capital Management sold out of Repligen (RGEN) in Q1 2022, closing a stake of 3,700 shares — an estimated $980K sold.
Boulder Hill Capital Management first reported a position in RGEN in Q4 2021 and held it in 1 quarter. The position peaked at $980K in Q4 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- Boulder Hill Capital Management reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
- Boulder Hill Capital Management sold 3,700 Repligen shares in Q1 2022, an estimated $980K.
- Boulder Hill Capital Management first reported a position in Repligen in Q4 2021 and held it in 1 quarter.
- Boulder Hill Capital Management's Repligen position peaked at $980K in Q4 2021.
- 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on Boulder Hill Capital Management's 13F filing for Q1 2022, filed 12 May 2022.